Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase I/IIa, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of PEN-866 in Patients With Advanced Solid Malignancies

Summary

07/14/2021 NOTE: This trial is currently enrolling into the Phase Ib cohort PEN-866 with 5-FU for patients with pancreatic cancer. The purpose of this phase I/IIb study is to evaluate PEN-866 in patients with advanced solid malignancies whose disease has progressed after treatment with previous anticancer therapies. Patients may contact Laura Mei or Leila Alland at clinical.information@tarveda.com for more information.

General Information

NCT#: NCT03221400
Study ID: PEN-866-001
Trial Phase: Phase I/II

Trial Sponsor: Tarveda Therapeutics
Therapies Used in This Trial: Fluorouracil, Leucovorin, PEN-866, Niraparib

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search